TOMANIN, ROSELLA
 Distribuzione geografica
Continente #
NA - Nord America 1861
EU - Europa 229
AS - Asia 125
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2216
Nazione #
US - Stati Uniti d'America 1861
CN - Cina 96
SE - Svezia 83
IT - Italia 50
FI - Finlandia 32
VN - Vietnam 20
DE - Germania 19
UA - Ucraina 18
GB - Regno Unito 14
IN - India 8
IE - Irlanda 5
ES - Italia 2
FR - Francia 2
RU - Federazione Russa 2
SI - Slovenia 2
EU - Europa 1
KR - Corea 1
Totale 2216
Città #
Fairfield 316
Houston 270
Chandler 199
Ann Arbor 186
Woodbridge 171
Seattle 128
Cambridge 120
Wilmington 120
Ashburn 107
Jacksonville 49
Beijing 41
Princeton 38
Padova 31
San Diego 29
Des Moines 25
Medford 24
Dong Ket 20
Nanjing 18
Boardman 13
Helsinki 13
Falls Church 9
Roxbury 7
Shenyang 6
Brissago Valtravaglia 5
Dublin 5
Jinan 5
Munich 4
Auburn Hills 3
Changsha 3
Nanchang 3
Aprilia 2
Borås 2
Fremont 2
Haikou 2
Kharkiv 2
Lanzhou 2
Phoenix 2
Camposampiero 1
Chioggia 1
Chongqing 1
Durham 1
Guangzhou 1
Hebei 1
Hefei 1
Huzhou 1
Indiana 1
Jiaxing 1
Jinhua 1
New York 1
Ningbo 1
Norwalk 1
Pescara 1
Redwood City 1
Rimini 1
Rockville 1
Rome 1
San Francisco 1
Sant'elena 1
Shanghai 1
Taizhou 1
Tianjin 1
Zhengzhou 1
Totale 2007
Nome #
High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors 157
Perturbations in cell signaling elicit early cardiac defects in mucopolysaccharidosis type II 155
Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment 135
QueryOR: a comprehensive web platform for genetic variant analysis and prioritization 121
RNA-seq Transcriptome Profiling Of Primary Hunter Cells Following Treatment With Recombinant IDS As A First Step For Identification Of ERT Efficacy Markers 120
Gene therapy of Hunter syndrome: Evaluation of the efficiency of muscle electro genetransfer for the production and release of recombinant iduronate-2-sulfatase (IDS) 114
A Hunter Patient with a Severe Phenotype Reveals Two Large Deletions and Two Duplications Extending 1.2 Mb Distally to IDS Locus 101
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders 94
Reduction of GAG storage in MPS II mouse model following implantation of encapsulated recombinant myoblasts 92
Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved 87
A column-switching HPLC-MS/MS method for mucopolysaccharidosis type I analysis in a multiplex assay for the simultaneous newborn screening of six lysosomal storage disorders. 86
Brain RNA-seq profiling of the mucopolysaccharidosis type II mouse model 84
Uptake of recombinant iduronate-2-sulfatase into neuronal and glial cells in vitro 82
Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction 80
FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII). 77
Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II. 75
A rapid testing procedure for Fabry disease: alpha-galadosidase A assay in dried blood spots 74
BBB Crossing in Lysosomal Storage Disorders: A Nanoparticle-Based Approach 68
Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years 68
Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases. 58
Antiretroviral activity of furocoumarins plus UVA light detected by a replication-defective retrovirus 54
Targeting brain disease in MPSII: Preclinical evaluation of IDS-loaded PLGA nanoparticles 53
Rapid diagnostic testing procedures for lysosomal storage disorders: alpha-glucosidase and beta-galactosidase assays on dried blood spots 39
Exploiting the potential of drosophila models in lysosomal storage disorders: Pathological mechanisms and drug discovery 28
Evaluation of the antiviral activity of psoralens. G. Miolo, R. Tomanin, A. De Rossi, F. Dall'Acqua, F. Zacchello, M. Scarpa. 27
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study 27
Setup and Validation of a Targeted Next-Generation Sequencing Approach for the Diagnosis of Lysosomal Storage Disorders 27
A replication defective retrovirus model for the identification of psoralens with antiretroviral activity. 23
Drosophila d-idua reduction mimics mucopolysaccharidosis type i disease-related phenotypes 23
Mucopolysaccharidosis type II: One hundred years of research, diagnosis, and treatment 18
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy 3
Totale 2250
Categoria #
all - tutte 3761
article - articoli 3672
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201845 0000 00 011 49210
2018/2019208 23210 11 38 0447352
2019/2020536 55132867 5235 4354 55685115
2020/2021411 23153124 1531 1131 531053339
2021/2022477 22375730 6436 3034 3694181
2022/2023277 5940958 4566 00 0000
Totale 2250